Shares in biotechnology business Nyrada (ASX: NYR) lifted by nearly 40 per cent on Wednesday following the successful completion of safety studies on its lead drug candidate for the treatment of traumatic brain injury and strokes, NYR-BI03. The favourable results have now opened the door for a first clinical trial of the drug on humans
Read More
Clean energy and high-tech materials company AnteoTech (ASX: ADO) has received a first commercial order for its proprietary Ultranode battery anode technology which contains 70 per cent silicon. The initial $40,000 purchase will see an unnamed “major” European electric vehicle (EV) manufacturer – known as EV1 – test and evaluate the technology over the coming
Read More
Shares in mineral exploration business African Gold (ASX: A1G) more than doubled on Tuesday after the company delivered “spectacular” gold intercepts from drilling at its Didievi project in the West African nation of Côte d’Ivoire. The new results from one diamond drill hole at the Blaffo Guetto prospect were headlined by a broad and high-grade
Read More
James Bay Minerals (ASX: JBY) (‘James Bay’) has entered a binding agreement that gives the Company the right to acquire up to 100% of the advanced Independence Gold Project, located in Nevada, United States of America. The Independence Project is presently owned by Independence Mining LLC, an incorporated joint venture between Battle Mountain Resources Pty
Read More
Diversified mining titan Rio Tinto (ASX: RIO) is set to purchase the “world-class” lithium chemical producer Arcadium Lithium in an effort to grow its position as a global leader in the production of energy transition commodities. Valued at US$6.7 billion, the all-cash deal represents a sturdy 90 per cent premium to Arcadium’s closing share price
Read More
Medical technology company Echo IQ (ASX:EIQ) has employed leading American healthcare executive, Dustin Haines, as new chief executive officer (CEO) to spearhead efforts to commercialise and scale its EchoSolv artificial intelligence powered platform in the lucrative US market. The innovative platform is designed to automatically identify patients at risk of structural heart disease with unparalleled
Read More